1 insider bought €2.9M of shares over the last 90 days, the latest by Wen Shu Hao, filed 21 Oct 2026.
XtalPi Holdings Ltd. is a Health Care company. Its directors and officers file their transactions with HKEX. In the past year (22 October 2025 to 22 October 2026), 18 filings came from 7 insiders.
Purchases and sales both appear in the filings: 9 purchases (4 insiders, €2.9M) and 4 sales (3 insiders, €52k). The totals exclude 8 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €1.1M, the purchase published on 8 October 2026 by Wen Shu Hao is the largest of the period (0.027% of market cap). Those buying include 4 senior executives.
Across the 1,314 companies tracked on its exchange, the median is 4 filings; at 18 filings, this issuer sits above that mark. Over the whole record (from 2024), the tally stands at 12 purchases and 7 sales.
The clock since the last published purchase (21 October 2026) now reads 3 days. The median gap between a trade and its publication by HKEX is 4 days. This delay matters because a trade only becomes useful information once it is public.
Other companies in the same sector with recent insider buying flagged by our signals: UCB. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
+1 other insider
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 33 declarations
XtalPi Holdings Ltd. is a company in the health and pharmaceutical sector, providing AI-based solutions for drug development. It is listed on the Hong Kong Stock Exchange.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 6 filings published between 4 September and 21 October 2026: 4 open-market purchases by insiders for €2.9M, 2 sales (amount not disclosed). Largest amounts: Wen Shu Hao (Director), purchases of €2.9M.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 22 October 2026 (UTC)